Sathe; Dhananjay G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sathe; Dhananjay G..The latest application filed is for "novel process for the preparation of filgotinib and intermediates thereof".

Company Profile

11.12.13

Sathe; Dhananjay G. - Thane IN
Sathe; Dhananjay G. - Maharashtra IN
Sathe; Dhananjay G - Maharashtra IN
Sathe; Dhananjay G. - Maharashtra State IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Process for the Preparation of Filgotinib and Intermediates Thereof App 20220185810 - Sathe; Dhananjay G. ; et al.	2022-06-16
Process For The Preparation Of Rivaroxaban Involving Novel Intermediate App 20210387979 - SATHE; Dhananjay G. ; et al.	2021-12-16
Process for the preparation of rivaroxaban involving novel intermediate Grant 11,034,683 - Sathe , et al. June 15, 2	2021-06-15
Process For The Preparation Of Opicapone And Intermediates Thereof App 20210087183 - SATHE; Dhananjay G. ; et al.	2021-03-25
Process to prepare n-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulphonyl) ethyl]-1, 3-dioxo-2,3-dihydro-1h-isoindol-4yl]acetamide Grant 10,919,855 - Sathe , et al. February 16, 2	2021-02-16
Process for preparation and purification of vortioxetine hydrobromide Grant 10,836,730 - Sathe , et al. November 17, 2	2020-11-17
Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine Grant 10,829,450 - Sathe , et al. November 10, 2	2020-11-10
Novel Process To Prepare N-[2-[(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulphonyl) Ethyl]-1, 3-dioxo-2,3-dihydro-1h-isoindol-4 App 20200181085 - Sathe; Dhananjay G. ; et al.	2020-06-11
Improved Process For The Preparation Of Rivaroxaban Involving Novel Intermediate App 20200017487 - SATHE; Dhananjay G. ; et al.	2020-01-16
An Improved Process For Preparation And Purification Of Vortioxetine Hydrobromide App 20200010429 - SATHE; Dhananjay G. ; et al.	2020-01-09
Process for the preparation of lacosamide Grant 10,414,720 - Sathe , et al. Sept	2019-09-17
Process for the preparation of apixaban and intermediates thereof Grant 10,336,753 - Sathe , et al.	2019-07-02
Process for the preparation of ranolazine Grant 10,266,507 - Sathe , et al.	2019-04-23
Process for the preparation of Apixaban and intermediates thereof Grant 10,208,036 - Sathe , et al. Feb	2019-02-19
Process For The Preparation Of Apixaban And Intermediates Thereof App 20180362528 - Sathe; Dhananjay G. ; et al.	2018-12-20
Process for the preparation of Apixaban and intermediates thereof Grant 10,118,924 - Sathe , et al. November 6, 2	2018-11-06
Process for the Preparation of (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE App 20180134661 - Sathe; Dhananjay G. ; et al.	2018-05-17
Process for the preparation of (3R,4R)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine Grant 9,951,012 - Sathe , et al. April 24, 2	2018-04-24
Process for the preparation of apixaban and intermediates thereof Grant 9,908,881 - Sathe , et al. March 6, 2	2018-03-06
Process of preparing potassium salt of Azilsartan medoxomil Grant 9,902,717 - Sathe , et al. February 27, 2	2018-02-27
Novel Process For The Preparation Of Ranolazine App 20180044307 - SATHE; Dhananjay G. ; et al.	2018-02-15
Process for the Preparation of (3R,4R)-(1-BENZYL-4-METHYLPIPERIDIN-3-YL)-METHYLAMINE App 20180037551 - Sathe; Dhananjay G. ; et al.	2018-02-08
Process For The Preparation Of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine App 20170240510 - Sathe; Dhananjay G. ; et al.	2017-08-24
Process of Preparing Potassium Salt of Azilsartan Medoxomil App 20170197951 - Sathe; Dhananjay G. ; et al.	2017-07-13
An Improved Process For The Preparation Of (3r,4r)-(1-benzyl-4-methylpiperidin-3-yl)-methylamine App 20160102057 - SATHE; Dhananjay G. ; et al.	2016-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.